Bonesupport Lands CE Mark for Next-Gen Antibiotic Bone Graft Substitute
Swedish orthopedic company Bonesupport touts European regulatory approval for its next-generation Cerament|G resorbable, antibiotic bone substitute.
Swedish orthopedic trauma products maker Bonesupport won CE Mark approval in the European Union for its next-generation Cerament|G injectable antibiotic-eluting bone substitute.
The Cerament|G product is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis. The resorbable bone graft substitute is designed to remodel into healthy bone within 6-12 months while preventing colonization of microorganisms, especially in cases of deep bone infection.